Xinyan Zhang

Xinyan Zhang has extensive work experience in the field of biostatistics. They currently hold the position of Executive Director, Head of Biometrics at Nimbus Therapeutics since April 2023. Prior to this, Zhang worked as a Senior Director of Biometrics at Nimbus Therapeutics from March 2022 to April 2023. Before joining Nimbus Therapeutics, Zhang served as the Director of Biostatistics at bluebird bio from August 2020 to March 2022. They also held positions at Sanofi, where they worked as an Associate Director of Biostatistics from December 2018 to August 2020, and as a Senior Manager of Biostatistics from September 2016 to December 2018. Zhang's earlier work experience includes a role as a Manager of Biostatistics at AbbVie from November 2013 to September 2016, and as a Research Associate at Harvard T.H. Chan School of Public Health from August 2010 to November 2013. Zhang began their career as an Intern Biostatistician at GlaxoSmithKline in 2008.

Xinyan Zhang pursued a Doctor of Philosophy (PhD) degree in Statistics from the University of Missouri-Columbia, attending from 2005 to 2010.